vs

Side-by-side financial comparison of APOGEE ENTERPRISES, INC. (APOG) and CONMED Corp (CNMD). Click either name above to swap in a different company.

APOGEE ENTERPRISES, INC. is the larger business by last-quarter revenue ($351.4M vs $317.0M, roughly 1.1× CONMED Corp). APOGEE ENTERPRISES, INC. runs the higher net margin — 4.7% vs 4.4%, a 0.4% gap on every dollar of revenue. On growth, APOGEE ENTERPRISES, INC. posted the faster year-over-year revenue change (1.6% vs -1.3%). Over the past eight quarters, APOGEE ENTERPRISES, INC.'s revenue compounded faster (2.9% CAGR vs -2.3%).

Apogee Electronics is an American manufacturer of audio interfaces, analog-to-digital and digital-to-analog converters, USB & iOS microphones, and audio production software.

The CONMED Corporation is a publicly traded American manufacturer of medical equipment and surgical devices, primarily in the orthopedic, laparoscopic and general surgery, and patient care areas. CONMED's headquarters is in Largo, Florida. Prior to July 2022, it was in Utica, New York. CONMED embraces a people-first culture that starts with a mission to support their healthcare partners and the patients they serve. They have manufacturing facilities in the United States and Mexico, offices in...

APOG vs CNMD — Head-to-Head

Bigger by revenue
APOG
APOG
1.1× larger
APOG
$351.4M
$317.0M
CNMD
Growing faster (revenue YoY)
APOG
APOG
+2.9% gap
APOG
1.6%
-1.3%
CNMD
Higher net margin
APOG
APOG
0.4% more per $
APOG
4.7%
4.4%
CNMD
Faster 2-yr revenue CAGR
APOG
APOG
Annualised
APOG
2.9%
-2.3%
CNMD

Income Statement — Q4 FY2026 vs Q1 FY2026

Metric
APOG
APOG
CNMD
CNMD
Revenue
$351.4M
$317.0M
Net Profit
$16.6M
$13.8M
Gross Margin
22.4%
57.9%
Operating Margin
7.3%
8.0%
Net Margin
4.7%
4.4%
Revenue YoY
1.6%
-1.3%
Net Profit YoY
568.8%
129.1%
EPS (diluted)
$0.78
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APOG
APOG
CNMD
CNMD
Q1 26
$351.4M
$317.0M
Q4 25
$348.6M
$373.2M
Q3 25
$358.2M
$337.9M
Q2 25
$346.6M
$342.3M
Q1 25
$345.7M
$321.3M
Q4 24
$341.3M
$345.9M
Q3 24
$342.4M
$316.7M
Q2 24
$331.5M
$332.1M
Net Profit
APOG
APOG
CNMD
CNMD
Q1 26
$16.6M
$13.8M
Q4 25
$16.5M
Q3 25
$23.6M
$2.9M
Q2 25
$-2.7M
$21.4M
Q1 25
$2.5M
$6.0M
Q4 24
$21.0M
Q3 24
$30.6M
$49.0M
Q2 24
$31.0M
$30.0M
Gross Margin
APOG
APOG
CNMD
CNMD
Q1 26
22.4%
57.9%
Q4 25
23.8%
58.5%
Q3 25
23.1%
49.2%
Q2 25
21.7%
55.0%
Q1 25
21.6%
55.3%
Q4 24
26.1%
57.3%
Q3 24
28.4%
56.5%
Q2 24
29.8%
55.3%
Operating Margin
APOG
APOG
CNMD
CNMD
Q1 26
7.3%
8.0%
Q4 25
7.1%
9.8%
Q3 25
7.5%
3.5%
Q2 25
2.0%
11.1%
Q1 25
1.8%
5.0%
Q4 24
8.4%
15.2%
Q3 24
12.3%
20.7%
Q2 24
12.5%
14.2%
Net Margin
APOG
APOG
CNMD
CNMD
Q1 26
4.7%
4.4%
Q4 25
4.7%
Q3 25
6.6%
0.8%
Q2 25
-0.8%
6.3%
Q1 25
0.7%
1.9%
Q4 24
6.1%
Q3 24
8.9%
15.5%
Q2 24
9.4%
9.0%
EPS (diluted)
APOG
APOG
CNMD
CNMD
Q1 26
$0.78
$0.45
Q4 25
$0.77
$0.54
Q3 25
$1.10
$0.09
Q2 25
$-0.13
$0.69
Q1 25
$0.12
$0.19
Q4 24
$0.96
$1.09
Q3 24
$1.40
$1.57
Q2 24
$1.41
$0.96

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APOG
APOG
CNMD
CNMD
Cash + ST InvestmentsLiquidity on hand
$39.5M
Total DebtLower is stronger
$232.3M
Stockholders' EquityBook value
$511.8M
Total Assets
$1.1B
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APOG
APOG
CNMD
CNMD
Q1 26
$39.5M
Q4 25
$41.3M
Q3 25
$39.5M
Q2 25
$32.8M
Q1 25
$41.4M
Q4 24
$43.9M
Q3 24
$51.0M
Q2 24
$30.4M
Total Debt
APOG
APOG
CNMD
CNMD
Q1 26
$232.3M
Q4 25
$834.2M
Q3 25
$853.0M
Q2 25
$881.1M
Q1 25
$285.0M
$891.4M
Q4 24
$905.1M
Q3 24
$940.1M
Q2 24
$965.2M
Stockholders' Equity
APOG
APOG
CNMD
CNMD
Q1 26
$511.8M
Q4 25
$512.3M
$1.0B
Q3 25
$500.2M
$1.0B
Q2 25
$481.8M
$1.0B
Q1 25
$487.9M
$977.6M
Q4 24
$522.1M
$962.7M
Q3 24
$506.4M
$932.9M
Q2 24
$480.0M
$881.8M
Total Assets
APOG
APOG
CNMD
CNMD
Q1 26
$1.1B
Q4 25
$1.1B
$2.3B
Q3 25
$1.2B
$2.3B
Q2 25
$1.2B
$2.3B
Q1 25
$1.2B
$2.3B
Q4 24
$1.2B
$2.3B
Q3 24
$917.1M
$2.3B
Q2 24
$889.0M
$2.3B
Debt / Equity
APOG
APOG
CNMD
CNMD
Q1 26
0.45×
Q4 25
0.81×
Q3 25
0.85×
Q2 25
0.88×
Q1 25
0.58×
0.91×
Q4 24
0.94×
Q3 24
1.01×
Q2 24
1.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APOG
APOG
CNMD
CNMD
Operating Cash FlowLast quarter
$122.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
7.8%
Cash ConversionOCF / Net Profit
7.37×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APOG
APOG
CNMD
CNMD
Q1 26
$122.5M
Q4 25
$29.3M
$46.3M
Q3 25
$57.1M
$53.7M
Q2 25
$-19.8M
$29.1M
Q1 25
$30.0M
$41.5M
Q4 24
$31.0M
$43.3M
Q3 24
$58.7M
$51.2M
Q2 24
$5.5M
$43.3M
Free Cash Flow
APOG
APOG
CNMD
CNMD
Q1 26
Q4 25
$22.9M
$41.2M
Q3 25
$52.4M
$48.5M
Q2 25
$-26.9M
$23.4M
Q1 25
$19.1M
$37.8M
Q4 24
$22.0M
$39.3M
Q3 24
$50.2M
$47.8M
Q2 24
$-1.8M
$39.7M
FCF Margin
APOG
APOG
CNMD
CNMD
Q1 26
Q4 25
6.6%
11.0%
Q3 25
14.6%
14.4%
Q2 25
-7.8%
6.8%
Q1 25
5.5%
11.8%
Q4 24
6.4%
11.4%
Q3 24
14.7%
15.1%
Q2 24
-0.5%
12.0%
Capex Intensity
APOG
APOG
CNMD
CNMD
Q1 26
7.8%
Q4 25
1.9%
1.4%
Q3 25
1.3%
1.5%
Q2 25
2.1%
1.7%
Q1 25
3.2%
1.2%
Q4 24
2.6%
1.2%
Q3 24
2.5%
1.1%
Q2 24
2.2%
1.1%
Cash Conversion
APOG
APOG
CNMD
CNMD
Q1 26
7.37×
Q4 25
1.77×
Q3 25
2.41×
18.78×
Q2 25
1.36×
Q1 25
12.08×
6.88×
Q4 24
1.48×
Q3 24
1.92×
1.05×
Q2 24
0.18×
1.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APOG
APOG

Architectural Services$127.1M36%
Architectural Metals$110.0M31%
Architectural Glass$67.4M19%
Performance Surfaces$54.3M15%

CNMD
CNMD

Segment breakdown not available.

Related Comparisons